Forget the crappy caregiver bots and puppy-eyed seals. When my parents got sick, I turned to a new generation of roboticists—and their glowing, talking, blobby creations. This article first appeared in the January, 2024 edition of Wired. Her research was supported by an Alicia Patterson
For scientists who perform medical research on the recently deceased, there are few regulatory or ethical guardrails. This article, written by Jyoti Madhusoodanan, is based on her 2023 Alicia Patterson Foundation fellowship research on human experiments and greater openness behind clinical trials. It appeared in
Illustration by Karol Banach In August 2021, Amol Akhade, an oncologist at Nair Medical Hospital in Mumbai, India, received an e-mail from the Swiss drug manufacturer Roche recommending the use of a drug named atezolizumab to treat a specific kind of breast cancer. Akhade was
AMES, IOWA – In a gathering that drew the attendance of both farmers and Wall Street financiers, US regulators joined with oil giant Chevron at a November conference here to promote what backers promise will be a monumental breakthrough – systemic changes that would turn
Billions in clean energy incentives rely on raw materials from polluting corn and livestock. This report was made possible by an investigative reporting fellowship awarded by the Alicia Patterson Foundation. A version of this article was co-published by Circle of Blue, The New Lede and
